Sources | Names Used |
---|---|
CTRPv2 | UNC0638:navitoclax (1:1 mol/mol) |
PharmacoGx | UNC0638:navitoclax (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZPR1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | ZSCAN16 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | ZSCAN25 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ZSWIM4 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ZYG11B | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |